Interview with Swee-Yeok CHU, CEO & President, EDBI/Bio One Capital
As the CEO of EDBI since late 2008, what would you say have been the main developments of the agency during this time? EDBI is the strategic corporate investment arm…
Address: 250 North Bridge Road,#28-00 Raffles City Tower, Singapore 179101,Singapore
Tel: +65 6832 6832
Web: http://www.edbi.com/
Bio One Capital is a leading strategic investment firm headquartered in Singapore with a worldwide presence investing to drive growth opportunities within the knowledge and innovation-intensive sectors of Biomedical Sciences, Clean Technologies, Internet & Digital Media, as well as other strategic industry clusters with commercial potential. As a value adding investor, they create sustainable and synergistic partnerships with their portfolio companies, leveraging on their broad network of resources and experience to facilitate the companies’ organic growth in Asia and the world, through their operations in Singapore
Investment firm
As the CEO of EDBI since late 2008, what would you say have been the main developments of the agency during this time? EDBI is the strategic corporate investment arm…
The Asia-Pacific region is a vast geographic area, home to almost half of the world’s population and numerous emerging and developed markets with great investment potential for healthcare and life…
Singapore has pioneered multiple aspects of QuintilesIMS’s global business, and the high profile merger has created interesting opportunities for the organization within the APAC region, beyond strong synergies at the…
Peter Ulvskjold, the Corporate Vice President of International Operations in Southeast Asia, highlights the challenges in the region facing diabetics and how Novo Nordisk is working to close the gaps…
In an exclusive interview with Tom Page, the Vice President of Contract Logistics and Health Care Asia pacific at UPS, he emphasizes the strategic importance of Singapore as a logistics…
With healthcare demand rapidly increasing in Asia Pacific and worldwide, the entire healthcare sector is sure to undergo a dramatic revolution. J&J Medical’s Chairman for Asia Pacific discusses his priorities…
As the world’s best airport, Changi Airport is also a fast growing hub for pharma freight shipping, and has demonstrated significant leadership in the world of pharma logistics hubs while…
What role has Southeast Asia played within Evonik’s global business since you became regional president? Peter Meinshausen (PM): Considering Southeast Asia to consist of the ASEAN countries, we have seen…
In an exclusive interview with Brent Scott, President of Asia for Stryker, he highlights the growth potential of the region, Stryker’s aggressive acquisition strategy, and the strategic partnerships in the…
In an exclusive interview with Leslie Chua, the General Manager of the Solutions Division at Hitachi Medical Systems, he elaborates on how the division is building on the synergies of…
DKSH’s VP of Healthcare in Singapore and Malaysia, Dr. Varun Sethi deconstructs the essence of what it means to be a Market Expansion Services provider, while highlighting aspects of the…
The chairman of Singapore’s Medical Technology Industry Group, Albert Lee discusses the association’s key priorities, how they serve to advance the interests of both multinational and local members, and the…
In an exclusive interview, Zuellig Pharma CEO John Davison provides insight into the new Zuellig Health Solutions unit that is providing strategic, topline-focused services in order to support Pharma companies…
See our Cookie Privacy Policy Here